Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Abdominal Radiology
Published in: Abdominal Radiology 11/2020

01-11-2020 | Computed Tomography | Special Section: Urothelial Disorders

Commentary: Ureteral pseudodiverticulosis is diagnosable on computed tomography

Author: Neil F. Wasserman

Published in: Abdominal Radiology | Issue 11/2020

Login to get access

Excerpt

Ureteral pseudodiverticula or ureteral diverticulosis (UPD) is a rare condition of unknown etiology wherein one or multiple outpouchings ≤ 4 mm are visible on diagnostic imaging [1]. Its importance lies in the fact that it has a high association with uroepithelial cancer, mostly transitional cell carcinoma (TCC), at the time of the latter’s diagnosis [1, 2]. UPD has been reported in imaging studies to antedate the diagnosis of urinary tract cancer anywhere from 2 to 10 years [3]. …
Literature
1.
Wasserman NF, La Pointe S, Posalaky, IP. Ureteral pseudodiverticulosis. Radiology 1985; 155:561-566CrossRef
2.
Wasserman NF, Zhang G, Posalaky IP, Reddy PK. Ureteral pseudodiverticulosis: frequent association with uroepithelial malignancy. AJR 1991; 157:69-72CrossRef
3.
Kenney PJ, Wasserman NF. Ureteral pseudodiverticulosis: association with carcinoma of the renal pelvis. Urol Radiol 1987; 9:161-163CrossRef
4.
Morgan MA, Chua WY, Safar HM, Papanicaloua N, Ramchandani P. Ureteral pseudodiverticulosis and urothelial cell carcinoma: rethinking the association. Abdom Radiol 2019; 44:234-238CrossRef
5.
Miyazaki J, Hishiyama H. Epidemiology of urothelial carcinoma. International J Urol 2017; 24(10):730-734CrossRef
6.
Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res. 2011;46:399-424CrossRef
7.
8.
Metadata
Title
Commentary: Ureteral pseudodiverticulosis is diagnosable on computed tomography
Author
Neil F. Wasserman
Publication date
01-11-2020
Publisher
Springer US
Published in
Abdominal Radiology / Issue 11/2020
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-019-02081-5

Other articles of this Issue 11/2020

Abdominal Radiology 11/2020 Go to the issue

Hepatobiliary

Diagnostic performance of the LR-M criteria and spectrum of LI-RADS imaging features among primary hepatic carcinomas

Kidneys, Ureters, Bladder, Retroperitoneum

Differential diagnosis of hypervascular ultra-small renal cell carcinoma and renal angiomyolipoma with minimal fat in early stage by using thin-section multidetector computed tomography

Hepatobiliary

Prediction of liver regeneration in recipients after living-donor liver transplantation in using preoperative CT texture analysis and clinical features

Review

Fournier gangrene: pictorial review

Review

Magnetic resonance imaging of the prostate after focal therapy with high-intensity focused ultrasound

Review

Contrast-enhanced ultrasound imaging of the liver: a review of the clinical evidence for SonoVue and Sonazoid
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits